Skip to main content
    A

    Alterity Therapeutics Ltd (ATHE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.96
    +0.00 (+0.00%)

    Market Cap: $37.42M

    Last updated: Nov 17, 2026 at 10:57 AM ET

    Earnings

    Upcoming Estimates

    Results pendingPeriod ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Last 12 of 33 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -N/AN/A-----
    Sep 26EST
    Date TBD
    -N/AN/A-----
    Jun 26
    Reported Aug 28
    N/AN/AN/A-----
    Dec 25
    Reported Feb 25
    -0.38-0.23N/A-----
    Jun 25
    Reported Aug 4
    Not reported-0.67N/A-----
    Dec 24
    Reported Feb 3
    Not reported-0.11N/A--0
    No revisions (30d)
    -
    Jun 24
    Reported Aug 29
    0.00-0.05N/A--0
    No revisions (30d)
    -
    Dec 23
    Reported Apr 11
    0.00N/AN/A-----
    Jun 23
    Reported Jun 30
    0.00N/AN/A-----
    Mar 23
    Reported Jun 29
    Not reportedN/AN/A-----
    Dec 22
    Reported Feb 27
    Not reported-1.80N/A-----
    Sep 22
    Reported Nov 30
    Not reportedN/AN/A-----
    Jun 22
    Reported Aug 30
    -0.24-0.24N/A-----
    Mar 22
    Reported Jun 29
    Not reportedN/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-695.00%
    ROE-55.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio14.52xQuick Ratio14.52x
    Trading Statistics
    Beta-0.02Avg Volume223.46K
    52-Week High$5.8952-Week Low$1.70

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 34.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 31.9, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.26
    SMA 20$2.23
    SMA 50$2.99
    SMA 200$3.92
    EMA 10$2.18
    EMA 20$2.34
    EMA 50$2.89
    EMA 200$3.75

    MACD

    Line: -0.24Signal: -0.26Hist: 0.02

    ADX

    ADX: 20.5+DI: 21.5-DI: 27.7

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down96.0
    PSAR$3.20

    Bollinger Bands

    Upper Band$2.55
    Lower Band$1.90
    %B Position2886%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    31.9

    Momentum Oscillators

    Stoch %K13.1
    Stoch %D15.6
    Williams %R-83.6
    ROC (10d)-6.2%
    Momentum-0.13
    CCI (20d)-134.2
    MFI (14d)92.2

    Volatility Measures

    ATR (14d)$0.29(14.6%)
    StdDev (20d)0.16
    Hist Vol102.5%(High)

    Volume Flow

    VWAP$1.97
    OBV8.3M
    AD Line-2.1M
    CMF (20d)-0.376

    Volume Metrics

    Avg Vol (20d)233.5K
    Vol Ratio0.1x(Low)
    VWMA (20d)$2.44

    Pivot Points

    R3$2.60
    R2$2.37
    R1$2.16
    Pivot Point$1.93
    S1$1.73
    S2$1.50
    S3$1.29

    Advanced Oscillators

    TSI-30.60
    Ultimate Osc41.4
    KST-232.51

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about ATHE

    News

    ATHE Valuation

    ATHE Profitability: Margins, ROIC and FCF

    Alterity Therapeutics (ATHE) has an operating margin of -695.0% and a net margin of 0.0%.

    Operating margin
    -695.0%
    Net margin
    0.0%
    ROE
    -55.0%
    ATHE financial statements

    Alterity Therapeutics Competitors

    The companies most similar to Alterity Therapeutics (ATHE) include Plus Therapeutics, OS Therapies and Grace Therapeutics.

    Sector: Healthcare

    ATHE Analyst Ratings

    Alterity Therapeutics (ATHE) has a Buy consensus from 4 analysts: 4 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    1
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    ATHE Bull Case vs Bear Case

    Bear case

    • ATHE's quarterly revenue changed -79.0% year over year.

    Updated Sep 7, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About ATHE

    Does ATHE pay dividends?

    Alterity Therapeutics Ltd (ATHE) does not currently pay a regular dividend.

    What is ATHE's market cap?

    Alterity Therapeutics Ltd (ATHE) has a market capitalization of $37.42M with a current stock price of $1.96.

    How do analysts rate ATHE stock?

    4 analysts cover Alterity Therapeutics Ltd (ATHE): 1 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    ATHE pages: Overview, Financials

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.